CAS RN: 1142943-96-1

cyclopropanecarboxylic acid (5-bromo-[1,2,4]triazolo[1,5-a]pyridin-2-yl)-amide

Product Availability

Choose a grade to view its available package options.

1 package records1 with current stock1 grade group
Batch No.PackageAvailabilityWarehouseInquiry
Batchno.20250425 100mg / 250mg / 1g / 5g Confirm by inquiry Shanghai Inquiry
  • Product code: SSC-014129
GET A QUOTE
Historical Factory Record

Historical Supply Reference

This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.

  • Pack sizes on record: 5g
  • Available purity: >97%
  • Inventory rows with stock: 0
  • Bulk packaging: confirmed by inquiry
Request Bulk Quote

Reference Pack Sizes

Reference pack sizes are shown below. Final availability, packaging and delivery schedule are confirmed by inquiry.

Recorded sizes, purity and stock details for CAS 1142943-96-1
Pack Size Recorded Purity Available Qty Ship From Inquiry
5g >97% 0 Out of Stock Beijing Inquiry

1142943-96-1 / N-(5-bromo-[1,2,4]triazolo[1,5-a]pyridin-2-yl)cyclopropanecarboxamide

N-(5-bromo-[1,2,4]triazolo[1,5-a]pyridin-2-yl)cyclopropanecarboxamide | N-{5-BROMO-[1,2,4]TRIAZOLO[1,5-A]PYRIDIN-2-YL}CYCLOPROPANECARBOXAMIDE | N-(5-bromo-(1,2,4)triazolo(1,5-a)pyridin-2-yl)cyclopropanecarboxamide

Standard CAS: 1142943-96-1 Multi CAS: No

Basic Information

CAS
1142943-96-1
Multi CAS
No
Molecular Formula
C10H9BrN4O
Molecular Weight
281.110000
Exact Mass
279.995970
SMILES
C1CC1C(=O)NC2=NN3C(=N2)C=CC=C3Br
InChI
InChI=1S/C10H9BrN4O/c11-7-2-1-3-8-12-10(14-15(7)8)13-9(16)6-4-5-6/h1-3,6H,4-5H2,(H,13,14,16)
InChIKey
XLBCMNCPMMPNHH-UHFFFAOYSA-N
Synonyms
N-(5-bromo-[1,2,4]triazolo[1,5-a]pyridin-2-yl)cyclopropanecarboxamide N-{5-BROMO-[1,2,4]TRIAZOLO[1,5-A]PYRIDIN-2-YL}CYCLOPROPANECARBOXAMIDE N-(5-bromo-(1,2,4)triazolo(1,5-a)pyridin-2-yl)cyclopropanecarboxamide RefChem:828043 892-576-2

Computed Properties

Structural Parameters

Heavy atom count
16
Aromatic heavy atom count
9
Fraction Csp3
0.3
Rotatable bonds
2
H-bond acceptors
4
H-bond donors
1
Molar refractivity
62.04
TPSA
59.29

LogP / Solubility

WLOGP
1.84
MLOGP
1.63
XLogP3
1.7
Consensus LogP
1.72
Log S (ESOL)
-3.03
Class (ESOL)
Poorly soluble
Log S (Ali)
-3.19
Class (Ali)
Poorly soluble
Log S (SILICOS-IT)
-3.25
Class (SILICOS-IT)
Poorly soluble

ADME

GI absorption
High
BBB permeant
Yes
P-gp substrate
No
CYP1A2 inhibitor
Yes
CYP2C19 inhibitor
No
CYP2C9 inhibitor
No
CYP2D6 inhibitor
Yes
CYP3A4 inhibitor
No
Log Kp (skin permeation)
-3.13

Drug-likeness / Medicinal Chemistry

Lipinski
Yes
Ghose
No
Veber
Yes
Egan
Yes
Muegge
Yes
Bioavailability score
0.55
Brenk alerts
1
Leadlikeness
Yes
Synthetic Accessibility
1.5

Safety & Transport

GHS Hazard Statements
Not Classified Reported as not meeting GHS hazard criteria by 1 of 1 companies. For more detailed information, please visit ECHA C&L website.

Get In Touch

Contact Us